Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...
"This is changing the way we practice prostate cancer." ...
Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial In this global phase III ...
A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial. This is an ...
The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation ...
Self-examination behavior varied markedly: roughly 20% reported none in the prior year, while about one-third examined weekly ...
Researchers led by Mass General Brigham report that older adults who took a daily multivitamin for two years showed signs of ...
Initial treatments are underway in randomized study of Acorn’s personalized autologous injectable for improving facial ...
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results